Original Paper
Abstract
Background: Systemic inflammatory response syndrome (SIRS) is a serious postoperative complication among older adult surgical patients that frequently develops into sepsis or even death. Notably, the incidences of SIRS and sepsis steadily increase with age. It is important to identify the risk of postoperative SIRS for older adult patients at a sufficiently early stage, which would allow preemptive individualized enhanced therapy to be conducted to improve the prognosis of older adult patients. In recent years, machine learning (ML) models have been deployed by researchers for many tasks, including disease prediction and risk stratification, exhibiting good application potential.
Objective: We aimed to develop and validate an individualized predictive model to identify susceptible and high-risk populations for SIRS in older adult patients to instruct appropriate early interventions.
Methods: Data for surgical patients aged ≥65 years from September 2015 to September 2020 in 3 independent medical centers were retrieved and analyzed. The eligible patient cohort in the Third Affiliated Hospital of Sun Yat-sen University was randomly separated into an 80% training set (2882 patients) and a 20% internal validation set (720 patients). We developed 4 ML models to predict postoperative SIRS. The area under the receiver operating curve (AUC), F1 score, Brier score, and calibration curve were used to evaluate the model performance. The model with the best performance was further validated in the other 2 independent data sets involving 844 and 307 cases, respectively.
Results: The incidences of SIRS in the 3 medical centers were 24.3% (876/3602), 29.6% (250/844), and 6.5% (20/307), respectively. We identified 15 variables that were significantly associated with postoperative SIRS and used in 4 ML models to predict postoperative SIRS. A balanced cutoff between sensitivity and specificity was chosen to ensure as high a true positive as possible. The random forest classifier (RF) model showed the best overall performance to predict postoperative SIRS, with an AUC of 0.751 (95% CI 0.709-0.793), sensitivity of 0.682, specificity of 0.681, and F1 score of 0.508 in the internal validation set and higher AUCs in the external validation-1 set (0.759, 95% CI 0.723-0.795) and external validation-2 set (0.804, 95% CI 0.746-0.863).
Conclusions: We developed and validated a generalizable RF model to predict postoperative SIRS in older adult patients, enabling clinicians to screen susceptible and high-risk patients and implement early individualized interventions. An online risk calculator to make the RF model accessible to anesthesiologists and peers around the world was developed.
doi:10.2196/57486
Keywords
Introduction
Systemic inflammatory response syndrome (SIRS) is a nonhomeostatic, self-destructive, and uncontrollable inflammatory response of the whole body triggered by infection, trauma, or major operations [
]. Recognizing SIRS has been a prerequisite of suspecting potential sepsis and implementing decisions such as sample culturing for the source of infection, escalating antibiotic regimens, and the level of patient monitor and care [ , ]. Although there is a tendency to apply criteria including the Sequential Organ Failure Assessment (SOFA) score or quick SOFA score to identify the possibility of sepsis [ ], SIRS criteria has demonstrated higher sensitivity than the quick SOFA score [ ], and it has served as both useful inclusion criteria and therapeutic target of trials aiming to treat sepsis [ ]. Early identification of patients who will develop postoperative SIRS may enable clinicians to provide timely interventions to prevent sepsis and improve outcomes. It has been reported that the incidence of postoperative SIRS could be as high as 89% [ , ] in patients undergoing abdominal surgery, and the condition frequently developed into sepsis and even multiple organ dysfunction syndrome [ ]. A 13-fold increase in mortality was reported in patients with postoperative SIRS compared with those without SIRS [ ]. Notably, the incidences of SIRS and sepsis steadily increase with age, and octogenarians are almost twice as likely to develop sepsis than those aged less than 50 years [ , ]. Although standardized preoperative antibiotic prophylaxis has been recommended and clinically applied for older adult populations with a high risk of postoperative infection and SIRS, nearly one-quarter of older adult patients still develop SIRS within 3 days after surgery [ ]. Thus, it is important to identify the risk of postoperative SIRS for older adult patients at a sufficiently early stage, which would allow preemptive individualized enhanced therapy to be conducted to improve the prognosis of older adult patients.Compared with traditional biostatistical methods, machine learning (ML) methods hold the advantages of flexibility, scalability, and the ability to analyze diverse data types, which can be deployed for many tasks, such as risk stratification, diagnosis and classification, and survival predictions [
- ]. In recent years, there have been many ML models used to predict sepsis [ - ], the majority of which were developed in similar populations such as patients in the intensive care unit [ ]. However, only a few have focused on older adult surgical patients, and an ML model to predict postoperative SIRS has been rarely reported.The goal of our study was to use ML methods to develop an individualized predictive model for older adult surgical patients to screen for a susceptible population at a high risk for SIRS in order to instruct appropriate early interventions. Meanwhile, the generalizability of the model was validated with the data sets from the other 2 medical centers.
Methods
Setting, Dates, and Population
The study was performed based on the electronic health record (EHR) systems of 3 independent medical centers including the Third Affiliated Hospital of Sun Yat-sen University (Guangzhou, China), Lingnan Hospital of Sun Yat-sen University, and Yuedong Hospital of Sun Yat-sen University using data from surgical patients aged ≥65 years from 2015 to 2020.
During the retrospective enrollment, the inclusion criteria included (1) age ≥65 years, (2) patients who underwent general anesthetic with endotracheal intubation or laryngeal mask, and (3) patients who had preoperative antimicrobial prophylaxis. The exclusion criteria included (1) patients whose total intraoperative infusion volumes, fluid loss, or American Society of Anesthesiologists (ASA) classifications were not recorded and (2) patients diagnosed with SIRS before surgery or undergoing infectious surgeries.
Data Sources
The data comes from the EHR system of the 3 hospitals, which were established by extracting medical records from the hospital information system, laboratory information system, picture archiving and communication system (PACS), and Docare Anesthesia System (2005-2020 Medical System Co, Ltd), which enabled access to a comprehensive data set collected during hospital admissions, inpatient stays, and post-hospital follow-up visits, including demographic characteristics, daily documentation, laboratory tests, imaging results, and anesthesia records.
Outcome
SIRS was diagnosed according to the American College of Chest Physicians [
]. It was defined when 2 or more of the following criteria were present: (1) temperature <36 °C or ≥38 °C, (2) heart rate ≥90 bpm, (3) respiratory rate ≥20 bpm or arterial carbon dioxide tension <32 mm Hg, and (4) white blood cell count <4×109/L, ≥12×109/L, or >10% immature forms. The incidence of SIRS within 3 postoperative days was recorded in the study.Data Sets
Data sets from the 3 medical centers were created separately and included: (1) patient demographics such as age, gender, and smoking history; (2) preoperative complications, including diabetes, hypertension, and fever; (3) anesthesia records, including ASA, administration of ulinastatin, dexamethasone, methylprednisolone, and dexmedetomidine; (4) liquid management including volume of fluid loss, blood loss, and colloid input; (5) duration of surgery; (6) laboratory parameters, including alanine aminotransferase (ALT), white blood cell count, hemoglobin, creatinine, albumin, high-sensitivity C-reactive protein (hs-CRP), activated partial thromboplastin time, glucose, low-density lipoprotein, high-density lipoprotein, blood urea nitrogen (BUN), fibrinogen, thrombin time, lymphocyte, red blood cell count, indirect bilirubin. These variables were selected based on EHR availability and their relevance to SIRS risk according to the literature and clinical experience [
].For the purpose of developing and validating the ML models for risk prediction, the cohort of eligible patients from the Third Affiliated Hospital of Sun Yat-sen University was randomly divided into an 80% training set (2882 patients) and a 20% internal validation set (720 patients). In addition, 2 validation data sets were created with the eligible patients from the Lingnan Hospital and Yuedong Hospital for external validation. Based on the events per variable (EPV)-10 principle [
], this study has a sufficient sample size.Statistical Analysis and ML Model Training
This study was reported as per the Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research [
]. Categorical variables are expressed as number (%), and continuous variables that follow a normal distribution are expressed as mean (SD) or otherwise as median (IQR). The missing rates of the variables are shown in Table S1 in . Missing values were imputed on each of the 3 cohorts (hospitals) independently: Categorical variables were filled in using mode counts, and continuous variables were filled in using means. The outliers were eliminated based on clinical experience, and 0 variance variables were removed.We trained 4 different classical ML algorithms trained on the training set, including random forest (RF), XGBoost, logistic regression (LR), and multilayer perceptron (MLP) models. RF represents a bagging parallel integration algorithm, XGBoost represents a boosting algorithm; LR represents the most classical linear model, and MLP represents a neural network algorithm. Grid search was applied based on 5-fold cross-validation to find the optimal hyperparameters for each algorithm based on the training set. The formulas for the evaluation indicators in the models are provided in
.The performance of the 4 algorithms was compared, and the optimal model was selected for this study. A comparison between the optimal model and nomogram we established before [
] and was also conducted with the internal validation set. Note that the prepared data sets incurred a data imbalance problem. To address this problem, we used the synthetic minority oversampling technique (SMOTE) provided by the performanceEstimation package [ , ].The statistical analyses were all done using Python 3.7 [
- ] and R-3.6.2 [ ]. All results were considered statistically significant at P<.05.Ethical Considerations
The study protocol followed the principles of the Declaration of Helsinki and was approved by the Institutional Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University on July 27, 2022 (number [2019]02-609-04). The requirements for informed consent and clinical trial registration were waived by the committee.
Results
Study Cohorts and Characteristics
Among the 16,141 patients aged ≥65 years accessed from the EHR system, only 3602 patients who met the inclusion criteria were included in the development cohort, with 876 (24.3%) postoperative SIRS events. The development cohort was then randomly separated into the training set and the internal validation set, which consisted of 2882 and 720 patients, respectively. Meanwhile, 844 and 307 patients were finally included in the external validation-1 set (Lingnan Hospital) and the external validation-2 set (Yuedong Hospital), respectively (
).The characteristics of the 3 cohorts from different medical centers are shown in
. The incidence rates of postoperative SIRS in each of the 3 medical centers were 24.3% (876/3602), 29.6% (250/844), and 6.5% (20/307), respectively. The different incidences of SIRS across the 3 medical centers may result from factors such as different regional characteristics, economic development levels, patient characteristics, surgical procedures, and the medical and nursing team.Among the 3602 patients in the development cohort with a mean age of 70.0 years, 2144 (59.5%) were women, 2152 (59.7%) had comorbid hypertension, 1140 (31.6%) had comorbid diabetes, and 437 (12.1%) were smokers. In addition, 420 (11.7%) patients had preoperative fever, and 1330 (36.9%) were assessed as ASA III/IV/V preoperatively.
The characteristics of patients with or without postoperative SIRS in the development cohort are shown in
. Patients who ended up with SIRS (SIRS group vs the non-SIRS group) were mainly women (573/876, 65.4% vs 1571/2726, 57.6%, P<.001) and more likely to have been diagnosed with diabetes (334/876, 38.1% vs 806/2726, 29.6%, P<.001) and assessed as ASA III/IV/V preoperatively (472/876, 53.9% vs 858/2726, 31.5%, P<.001). With evident incidence of preoperative fever (182/876, 20.8% vs 238/2726, 8.7%, P<.001), the total volume of fluid loss, volume of blood loss, and duration of surgery were also significantly higher and longer in the SIRS group than in the non-SIRS group (700 [330-1200] mL vs 430 [200-800] mL, 100 [50.0-200] mL vs 50 [20.0-100] mL, 207 [133-310] min vs 150 [90-232] min, respectively; all P<.001). Additionally, laboratory indicators including hs-CRP, BUN, direct bilirubin (DBILI), and prothrombin time (PT) were higher in SIRS patients than in non-SIRS patients, whereas albumin was lower in SIRS patients (all P<.001; ).Characteristics | Development cohort (n=3602) | External validation-1 (n=844) | External validation-2 (n=307) | ||||||||
Postoperative SIRSa,n (%) | |||||||||||
No | 2726 (75.7) | 594 (70.4) | 287 (93.5) | ||||||||
Yes | 876 (24.3) | 250 (29.6) | 20 (6.5) | ||||||||
Demographics | |||||||||||
Age, (years), median (IQR) | 70.0 (67.0-75.0) | 70.0 (67.0-76.0) | 72.0 (67.2-78.8) | ||||||||
Gender, n (%) | |||||||||||
Female | 2144 (59.5) | 468 (55.5) | 169 (55) | ||||||||
Male | 1458 (40.5) | 376 (44.5) | 138 (45) | ||||||||
Hypertension, n (%) | |||||||||||
No | 1450 (40.3) | 313 (37.1) | 173 (56.4) | ||||||||
Yes | 2152 (59.7) | 531 (62.9) | 134 (43.6) | ||||||||
Diabetes, n (%) | |||||||||||
No | 2462 (68.4) | 526 (62.3) | 51 (54.8) | ||||||||
Yes | 1140 (31.6) | 318 (37.7) | 42 (45.2) | ||||||||
History of smoking, n (%) | |||||||||||
No | 3165 (87.9) | 755 (89.5) | 257 (86.2) | ||||||||
Yes | 437 (12.1) | 89 (10.5) | 41 (13.8) | ||||||||
Preoperative fever, n (%) | |||||||||||
No | 3182 (88.3) | 642 (76.1) | 290 (94.5) | ||||||||
Yes | 420 (11.7) | 202 (23.9) | 17 (5.54) | ||||||||
ASAbclassification, n (%) | |||||||||||
I/II | 2272 (63.1) | 509 (60.3) | 236 (76.9) | ||||||||
III/IV/V | 1330 (36.9) | 335 (39.7) | 71 (23.1) | ||||||||
Preoperative variables | |||||||||||
WBCc (109/L), median (IQR) | 6.41 (5.15-8.11) | 6.57 (5.38-8.66) | 6.69 (5.57-8.53) | ||||||||
Lymphocytes (109/L), median (IQR) | 1.60 (1.20-2.05) | 1.50 (1.09-1.96) | 1.73 (1.32-2.19) | ||||||||
RBCd (1012/L), median (IQR) | 4.27 (3.85-4.66) | 4.15 (3.74-4.62) | 4.29 (3.91-4.72) | ||||||||
HGBe (g/L), median (IQR) | 127 (113-138) | 124 (111-137) | 125 (111-136) | ||||||||
RDW-CVf (%), median (IQR) | 0.13 (0.13-0.14) | 0.13 (0.12-0.14) | 13.5 (12.9-14.4) | ||||||||
hs-CRPg (mg/L), median (IQR) | 6.41 (5.10-8.20) | 6.56 (5.30-8.66) | 10.0 (4.17-34.9) | ||||||||
Albumin (g/L), median (IQR) | 39.6 (36.2-42.7) | 39.0 (36.0-41.7) | 37.8 (34.3-40.8) | ||||||||
ALTh (U/L), median (IQR) | 17.0 (13.0-26.0) | 18.0 (13.0-28.0) | 19.0 (13.0-28.0) | ||||||||
TBILIi (umol/L), median (IQR) | 9.80 (7.00-13.9) | 10.3 (7.30-14.7) | 14.6 (11.2-19.5) | ||||||||
DBILIj (umol/L), median (IQR) | 3.10 (2.10-4.90) | 3.51 (2.30-5.55) | 3.40 (2.60-4.85) | ||||||||
IBILIk (umol/L), median (IQR) | 6.50 (4.50-9.10) | 6.50 (4.60-9.20) | 10.8 (8.15-14.4) | ||||||||
Glucose (mmol/L), median (IQR) | 5.42 (4.87-6.48) | 5.52 (4.83-6.69) | 5.43 (4.92-6.48) | ||||||||
Creatinine (umol/L), median (IQR) | 75.0 (61.0-90.0) | 79.0 (64.0-96.0) | 74.0 (62.4-89.4) | ||||||||
BUNl (mmol/L), median (IQR) | 5.67 (4.60-7.02) | 5.83 (4.70-7.58) | 5.66 (4.50-6.82) | ||||||||
LDLm (mmol/L), median (IQR) | 2.90 (2.24-3.59) | 2.87 (2.24-3.53) | 2.55 (2.06-2.99) | ||||||||
HDLn (mmol/L), median (IQR) | 1.05 (0.86-1.26) | 1.11 (0.92-1.33) | 1.21 (0.98-1.56) | ||||||||
PTo (seconds), median (IQR) | 13.2 (12.8-13.9) | 13.1 (12.5-13.8) | 11.1 (10.6-11.6) | ||||||||
APTTp (seconds), median (IQR) | 37.4 (34.9-40.0) | 36.3 (33.5-39.1) | 31.1 (29.2-33.7) | ||||||||
Fibrinogen (g/L), median (IQR) | 3.65 (3.08-4.52) | 3.67 (3.08-4.58) | 3.23 (2.83-3.92) | ||||||||
TTq (seconds), median (IQR) | 17.5 (17.5-17.5) | 17.0 (17.0-17.0) | 15.7 (14.9-16.4) | ||||||||
PTINRr, median (IQR) | 1.00 (0.96-1.06) | 0.99 (0.94-1.07) | 1.01 (0.96-1.05) | ||||||||
Intraoperative variables | |||||||||||
Ulinastatin, n (%) | |||||||||||
No | 2817 (78.2) | 627 (74.3) | 305 (99.3) | ||||||||
Yes | 785 (21.8) | 217 (25.7) | 2 (0.65) | ||||||||
Dexamethasone,n (%) | |||||||||||
No | 3222 (89.5) | 762 (90.3) | 303 (98.7) | ||||||||
Yes | 380 (10.5) | 82 (9.72) | 4 (1.3) | ||||||||
Dexmedetomidine,n (%) | |||||||||||
No | 2270 (63) | 566 (67.1) | 110 (35.8) | ||||||||
Yes | 1332 (37) | 278 (32.9) | 197 (64.2) | ||||||||
Methylprednisolone (mg), median (IQR) | 0.00 (0.00-0.00) | 0.00 (0.00-40.0) | 0.00 (0.00-40.0) | ||||||||
Total volume of fluid loss (mL), median (IQR) | 500 (220-900) | 505 (250-900) | 420 (220-808) | ||||||||
Volume of blood loss (mL), median (IQR) | 50.0 (20.0-150) | 100 (30.0-200) | 20.0 (10.0-80.0) | ||||||||
Intraoperative colloid (mL), median (IQR) | 500 (500-500) | 500 (500-500) | 500 (500-500) | ||||||||
Duration of surgery (min), median (IQR) | 163 (95.0-250) | 170 (105-253) | 140 (87.8-210) |
aSIRS: systemic inflammatory response syndrome.
bASA: American Society of Anesthesiologists.
cWBC: white blood cell count.
dRBC: red blood cell count.
eHGB: hemoglobin.
fRDW-CV: red blood cell distribution width-coefficient of variation.
ghs-CRP: high sensitivity C-reactive protein.
hALT: alanine aminotransferase.
iTBILI: total bilirubin.
jDBILI: direct bilirubin.
kIBILI: indirect bilirubin.
lBUN: blood urea nitrogen.
mLDL: low-density lipoprotein.
nHDL: high-density lipoprotein.
oPT: prothrombin time.
pAPTT: activated partial thromboplastin time.
qTT: thrombin time.
rPTINR: international normalized ratio of prothrombin time.
Characteristics | Development cohort | ||||||||||
Total (n=3602) | Non-SIRS (n=2726) | SIRS (n=876) | P value | ||||||||
Demographics | |||||||||||
Age (years), median (IQR) | 70.0 (67.0-75.0) | 70.0 (67.0-75.0) | 71.0 (67.0-76.2) | <.001 | |||||||
Gender, n (%) | <.001 | ||||||||||
Female | 2144 (59.5) | 1571 (57.6) | 573 (65.4) | ||||||||
Male | 1458 (40.5) | 1155 (42.4) | 303 (34.6) | ||||||||
Hypertension, n (%) | .76 | ||||||||||
No | 1450 (40.3) | 1093 (40.1) | 357 (40.8) | ||||||||
Yes | 2152 (59.7) | 1633 (59.9) | 519 (59.2) | ||||||||
Diabetes, n (%) | <.001 | ||||||||||
No | 2462 (68.4) | 1920 (70.4) | 542 (61.9) | ||||||||
Yes | 1140 (31.6) | 806 (29.6) | 334 (38.1) | ||||||||
History of smoking, n (%) | .001 | ||||||||||
No | 3165 (87.9) | 2423 (88.9) | 742 (84.7) | ||||||||
Yes | 437 (12.1) | 303 (11.1) | 134 (15.3) | ||||||||
Preoperative fever, n (%) | <.001 | ||||||||||
No | 3182 (88.3) | 2488 (91.3) | 694 (79.2) | ||||||||
Yes | 420 (11.7) | 238 (8.7) | 182 (20.8) | ||||||||
ASAaclassification, n (%) | <.001 | ||||||||||
I/II | 2272 (63.1) | 1868 (68.5) | 404 (46.1) | ||||||||
III/IV/V | 1330 (36.9) | 858 (31.5) | 472 (53.9) | ||||||||
Preoperative variables | |||||||||||
WBCb (109/L), median (IQR) | 6.41 (5.15-8.11) | 6.32 (5.07-7.88) | 6.80 (5.44-8.94) | <.001 | |||||||
Lymphocytes (109/L), median (IQR) | 1.60 (1.20-2.05) | 1.63 (1.23-2.05) | 1.54 (1.12-2.05) | .007 | |||||||
RBCc (1012/L), median (IQR) | 4.27 (3.85-4.66) | 4.28 (3.88-4.66) | 4.22 (3.73-4.65) | .006 | |||||||
HGBd (g/L), median (IQR) | 127 (113-138) | 127 (115-138) | 126 (110-139) | .04 | |||||||
RDW-CVe (%), median (IQR) | 0.13 (0.13-0.14) | 0.13 (0.12-0.14) | 0.13 (0.13-0.14) | <.001 | |||||||
hs-CRPf (mg/L), median (IQR) | 6.41 (5.10-8.20) | 6.31 (5.03-7.93) | 6.83 (5.46-9.20) | <.001 | |||||||
Albumin (g/L), median (IQR) | 39.6 (36.2-42.7) | 40.0 (36.6-42.9) | 38.2 (35.0-41.7) | <.001 | |||||||
ALTg (U/L), median (IQR) | 17.0 (13.0-26.0) | 17.0 (12.0-25.0) | 19.0 (14.0-32.0) | <.001 | |||||||
TBILIh (umol/L), median (IQR) | 9.80 (7.00-13.9) | 9.70 (6.90-13.5) | 10.2 (7.30-15.2) | <.001 | |||||||
DBILIi (umol/L), median (IQR) | 3.10 (2.10-4.90) | 3.00 (2.10-4.70) | 3.50 (2.30-5.50) | <.001 | |||||||
IBILIj (umol/L), median (IQR) | 6.50 (4.50-9.10) | 6.40 (4.60-8.90) | 6.60 (4.50-9.50) | .16 | |||||||
Glucose (mmol/L), median (IQR) | 5.42 (4.87-6.48) | 5.41 (4.87-6.41) | 5.43 (4.88-6.75) | .31 | |||||||
Creatinine (umol/L), median (IQR) | 75.0 (61.0-90.0) | 73.0 (60.0-88.0) | 78.0 (63.0-96.0) | <.001 | |||||||
BUNk (mmol/L), median (IQR) | 5.67 (4.60-7.02) | 5.59 (4.56-6.90) | 5.96 (4.69-7.42) | <.001 | |||||||
LDLl (mmol/L), median (IQR) | 2.90 (2.24-3.59) | 2.92 (2.26-3.59) | 2.81 (2.19-3.58) | .055 | |||||||
HDLm (mmol/L), median (IQR) | 1.05 (0.86-1.26) | 1.07 (0.88-1.28) | 1.02 (0.81-1.24) | <.001 | |||||||
PTn (seconds), median (IQR) | 13.2 (12.8-13.9) | 13.2 (12.7-13.8) | 13.4 (12.9-14.2) | <.001 | |||||||
APTTo (seconds), median (IQR) | 37.4 (34.9-40.0) | 37.2 (34.9-39.9) | 38.0 (35.0-41.3) | .001 | |||||||
Fibrinogen (g/L), median (IQR) | 3.65 (3.08-4.52) | 3.63 (3.09-4.44) | 3.77 (3.05-4.75) | .03 | |||||||
TTp (seconds); median (IQR)] | 17.5 (17.5-17.5) | 17.5 (17.5-17.5) | 17.5 (17.5-17.5) | .055 | |||||||
PTINRq, median (IQR) | 1.00 (0.96-1.06) | 1.00 (0.96-1.06) | 1.02 (0.97-1.09) | <.001 | |||||||
Intraoperative variables | |||||||||||
Ulinastatin, n (%) | <.001 | ||||||||||
No | 2817 (78.2) | 2214 (81.2) | 603 (68.8) | ||||||||
Yes | 785 (21.8) | 512 (18.8) | 273 (31.2) | ||||||||
Dexamethasone,n (%) | .81 | ||||||||||
No | 3222 (89.5) | 2436 (89.4) | 786 (89.7) | ||||||||
Yes | 380 (10.5) | 290 (10.6) | 90 (10.3) | ||||||||
Dexmedetomidine,n (%) | .01 | ||||||||||
No | 2270 (63) | 1749 (64.2) | 521 (59.5) | ||||||||
Yes | 1332 (37) | 977 (35.8) | 355 (40.5) | ||||||||
Methylprednisolone (mg), median (IQR) | 0 | 0 | 0 | <.001 | |||||||
Total volume of fluid loss (mL), median (IQR) | 500 (220-900) | 430 (200-800) | 700 (330-1200) | <.001 | |||||||
Volume of blood loss (mL), median (IQR) | 50.0 (20.0-150) | 50.0 (20.0-100) | 100 (50.0-200) | <.001 | |||||||
Intraoperative colloid (mL), median (IQR) | 500 (500-500) | 500 (500-500) | 500 (500-1000) | <.001 | |||||||
Duration of surgery (min), median (IQR) | 163 (95.0-250) | 150 (90.0-232) | 207 (133-310) | <.001 |
aASA: American Society of Anesthesiologists.
bWBC: white blood cell count.
cRBC: red blood cell count.
dHGB: hemoglobin.
eRDW-CV: red blood cell distribution width-coefficient of variation.
fhs-CRP: high sensitivity C-reactive protein.
gALT: alanine aminotransferase.
hTBILI: total bilirubin.
iDBILI: direct bilirubin.
jIBILI: indirect bilirubin.
kBUN: blood urea nitrogen.
lLDL: low-density lipoprotein.
mHDL: high-density lipoprotein.
nPT: prothrombin time.
oAPTT: activated partial thromboplastin time.
pTT: thrombin time.
qPTINR: international normalized ratio of prothrombin time.
The prognoses of the non-SIRS and SIRS groups in the development cohort are shown in
. Compared with the non-SIRS group, patients in the SIRS group were significantly more likely to develop postoperative complications that included hemorrhage (446/876, 50.9% vs 939/2726, 34.4%, P<.001), acute respiratory distress syndrome (14/876, 1.6% vs 2/2726, 0.1%, P<.001), cardiac arrest (10/876, 1.1% vs 5/2726, 0.2%, P<.001), agitation and delirium (65/876, 7.4% vs 32/2726, 1.2%, P<.001), coma (60/876, 6.8% vs 7/2726, 0.3%, P<.001), and acute kidney injury (81/876, 9.2% vs 55/2726, 2%, P<.001). Furthermore, SIRS patients had a longer median postoperative hospitalization (12.0 [8.0-19.0] days vs 7.0 [5.0-10.0] days, P<.001), higher median cost (¥91,846 [¥61,765-¥135.5] vs ¥56,542 [¥34,273-¥76,956], P<.001; a currency exchange rate of ¥1=US $0.14 is applicable), higher risk of postoperative intensive care unit admissions (273/876, 37.1% vs 79/2726, 3.3%, P<.001), and higher in-hospital mortality rate (21/876, 2.4% vs 10/2726, 0.4%, P<.001) than non-SIRS patients.Prognoses | Total cohort (n=3602) | Non-SIRS (n=2726) | SIRS (n=876) | P value | |||||
Postoperative complications, n (%) | |||||||||
Hemorrhage | 1385 (38.5) | 939 (34.4) | 446 (50.9) | <.001 | |||||
ARDSa | 16 (0.4) | 2 (0.1) | 14 (1.6) | <.001 | |||||
Cardiac arrest | 15 (0.4) | 5 (0.2) | 10 (1.1) | <.001 | |||||
Agitation and delirium | 97 (2.7) | 32 (1.2) | 65 (7.4) | <.001 | |||||
Coma | 67 (1.9) | 7 (0.3) | 60 (6.8) | <.001 | |||||
Acute kidney injury | 136 (3.8) | 55 (2) | 81 (9.2) | <.001 | |||||
Postoperative ICUb admission, n (%) | 352 (11.4) | 79 (3.3) | 273 (37.1) | <.001 | |||||
In-hospital death, n (%) | 31 (0.9) | 10 (0.4) | 21 (2.4) | <.001 | |||||
Postoperative hospital stay (days), median (Q1-Q3) | 8.0 (5.0-12.0) | 7.0 (5.0-10.0) | 12.0 (8.0-19.0) | <.001 | |||||
Total hospital stay (days), median (Q1-Q3) | 16.0 (11.0-22.0) | 15.0 (10.0-20.0) | 21.5 (15.0-32.0) | <.001 | |||||
Total cost (¥)c, median (Q1-Q3) | 62,434 (39,886-87,937) | 56,542 (34,273-76,956) | 91,846 (61,675-135,548) | <.001 |
aARDS: acute respiratory distress syndrome.
bICU: intensive care unit.
cA currency exchange rate of ¥1=US $0.14 is applicable.
Variable Selection
Details of the missing rates in each center for the 36 variables selected based on the literature and our clinical experience are shown in Table S1 in
, and the highly correlated variables with a correlation coefficient higher than 0.7 were deleted to avoid collinearity (based on the principle of keeping the variable with the highest area under the receiver-operating curve [AUC] in the independent prediction of postoperative SIRS; Figure S1 in ).Since partially relevant or less important features may negatively affect the performance of ML models, feature selection was performed on the development cohort using least absolute shrinkage and selection operator (LASSO) regression methods. As shown in
, the dimensionality was reduced to 15 features after LASSO, including preoperative fever, ASA, PT, hsCRP, BUN, diabetes, duration of surgery, ulinastatin, methylprednisolone, alanine aminotransferase, total volume of fluid loss, volume of blood loss, DBILI, albumin, and gender. Except albumin and gender, which were negatively associated with postoperative SIRS, all other features were positively associated with postoperative SIRS in older adult patients ( ).Characteristics | Correlation coefficient |
Preoperative fever | 0.104 |
ASAa classification | 0.101 |
PTb | 0.016 |
hs-CRPc | 0.005 |
BUNd | 0.004 |
Diabetes mellitus | 0.001 |
Duration of surgery | <0.001 |
Ulinastatin | <0.001 |
Methylprednisone | <0.001 |
ALTe | <0.001 |
Total volume of fluid loss | <0.001 |
Volume of blood loss | <0.001 |
DBILIf | <0.001 |
Albumin | –0.002 |
Gender | –0.005 |
aASA: American Society of Anesthesiologists.
bPT: prothrombin time.
chs-CRP: high-sensitivity C-reactive protein.
dBUN: blood urea nitrogen.
eALT: alanine aminotransferase.
fDBILI: direct bilirubin.
Model Construction, Internal Validation, and Horizontal Comparison
Finally, the 15 selected predictors were used in the 4 ML models, including RF, XGBoost, LR, and MLP, to predict postoperative SIRS. The performance of the different ML algorithms in the internal validation set are shown in
, and the calibration curves are presented in . The AUC of the RF model was 0.751 (95% CI 0.709-0.793) with the highest sensitivity of 0.682 and specificity of 0.681. The F1 score of the RF model (0.508) was the highest among the 4 ML models, and the Brier score (0.153) was also relatively higher. As a result, upon general consideration of the AUC, F1 score, Brier score, calibration curve, and the ability of subsequent cross-center promotion and application, we thought that the RF model demonstrated the best performance. Additionally, the performance of RF model in the internal validation set was compared with the nomogram [ ] we once established to predict postoperative SIRS in older patients ( ). The results showed that the RF model had a significantly higher AUC (AUC=0.751) than the nomogram (AUC=0.671) in the internal validation set, which further proved the generalizability of the RF model ( ). The internal validation results after applying SMOTE are shown in Table S2 in , where the AUC values increased for almost all ML algorithms except for LR and RF still exhibited the best performance with an AUC of 0.923.Metrics | Random forest | XGBoost | Logistic regression | Multilayer perceptron | Nomogram |
AUCa (95% CI) | 0.751 (0.709-0.793) | 0.744 (0.702-0.786) | 0.752 (0.711-0.793) | 0.756 (0.715-0.797) | 0.671 (0.648-0.694) |
Cutoff | 0.237 | 0.226 | 0.230 | 0.216 | 0.276 |
Sensitivity | 0.682 | 0.665 | 0.671 | 0.665 | 0.626 |
Specificity | 0.681 | 0.667 | 0.672 | 0.665 | 0.625 |
Accuracy | 0.682 | 0.666 | 0.672 | 0.665 | 0.626 |
F1 score | 0.508 | 0.489 | 0.496 | 0.488 | 0.448 |
PPVb | 0.404 | 0.387 | 0.393 | 0.386 | 0.349 |
NPVc | 0.871 | 0.863 | 0.866 | 0.862 | 0.839 |
Brier score | 0.153 | 0.153 | 0.151 | 0.154 | 0.174 |
aAUC: area under the receiver operating curve.
bPPV: positive predictive value.
cNPV: negative predictive value.
External Validation Performance
External validation of the developed RF algorithm was conducted with the eligible data from patients from Lingnan Hospital (external validation-1) and Yuedong Hospital (external validation-2). As shown in
, the RF model achieved relatively higher AUCs for the external validation-1 (0.759, 95% CI 0.723-0.795) and external validation-2 (0.804, 95% CI 0.746-0.863) sets. Moreover, the external validation-2 set demonstrated much higher sensitivity (lower false-negative rate) than the internal validation set (0.800 vs 0.682), and the specificity of the model was improved in both external validation sets. On the other hand, the negative predictive value was high, and the positive predictive value (PPV) was relatively low for all 3 validation sets since we chose a balanced cutoff between sensitivity and specificity to ensure as high a true positive (TP) as possible, which also results in a high false positive (FP) and low false negative. Notably, the PPV and F1 score of external validation-2 was very low due to the low incidence rate of postoperative SIRS (20/307, 6.5%) at Yuedong Hospital.After applying SMOTE, the performance of the RF model in the external validation set was basically the same as the model without SMOTE, with AUCs of 0.783 vs 0.759 in external validation set 1 and 0.784 vs 0.804 in external validation set 2, which further proves that the RF model has good generalizability to different validation populations and different data processing methods (Table S3 in
).Metrics | Internal validation | External validation-1 | External validation-2 |
AUCa (95% CI) | 0.751 (0.709-0.793) | 0.759 (0.723-0.795) | 0.804 (0.746-0.863) |
Cutoffb | 0.237 | 0.237 | 0.237 |
Sensitivity | 0.682 | 0.680 | 0.800 |
Specificity | 0.681 | 0.689 | 0.690 |
Accuracy | 0.682 | 0.686 | 0.697 |
F1 score | 0.508 | 0.562 | 0.256 |
PPVc | 0.404 | 0.479 | 0.152 |
NPVd | 0.871 | 0.836 | 0.980 |
aAUC: area under the receiver operating curve.
bWe chose a cutoff balanced between sensitivity and specificity.
cPPV: positive predictive value.
dNPV: negative predictive value.
Feature Importance Weight
The feature importance permutation was used to rank the levels of feature importance, which is defined as the decrease in a model score when a single feature value is randomly shuffled (
). The results showed that the total volume of fluid loss, duration of surgery, ASA, and volume of blood loss had a significant impact on the outcome, with higher importance weight values of 0.121, 0.119, 0.118, and 0.101, respectively ( ).Characteristics | Permutation importance scores, mean (SD) | Feature importance weight |
Total volume of fluid loss | 0.047 (0.002) | 0.121 |
Duration of surgery | 0.047 (0.001) | 0.119 |
ASAa | 0.046 (0.003) | 0.118 |
Volume of blood loss | 0.039 (0.001) | 0.101 |
hs-CRPb | 0.035 (0.002) | 0.088 |
Albumin | 0.034 (0.002) | 0.088 |
BUNc | 0.033 (0.000) | 0.085 |
DBILId | 0.024 (0.001) | 0.061 |
ALTe | 0.023 (0.001) | 0.060 |
PTf | 0.021 (0.001) | 0.053 |
Methylprednisolone | 0.011 (0.001) | 0.027 |
Preoperative fever | 0.011 (0.001) | 0.027 |
Ulinastatin | 0.008 (0.001) | 0.021 |
Gender | 0.006 (0.000) | 0.016 |
Diabetes mellitus | 0.005 (0.000) | 0.013 |
aASA: American Society of Anesthesiologists.
bhs-CRP: high sensitivity C-reactive protein.
cBUN: blood urea nitrogen.
dDBILI: direct bilirubin.
eALT: alanine aminotransferase.
fPT: prothrombin time.
Online Application
Figure S2 in
shows the online calculator for our RF model to predict the risk of postoperative SIRS in older adult patients, which can be found at [ ]. Users can quickly obtain the predicted probability of the patient’s postoperative SIRS risk by entering the values of the 15 predictors.Discussion
Principal Findings
In this study, we evaluated the ability of 4 ML algorithms including RF, XGBoost, LR, and MLP to predict postoperative SIRS in older adult patients based on eligible data from EHR systems and concluded that the RF model has moderately better performance than the other ML algorithms, with an AUC value of 0.751, highest sensitivity of 0.682, and specificity of 0.681. The RF model also exhibited better performance in the internal validation set than the nomogram we once established to predict postoperative SIRS in older patients. Furthermore, the applicability of the RF model was proved by external validation in the other 2 independent medical centers, with relatively higher AUC values of 0.759 and 0.804, indicating good reproducibility and generalizability of the model in older adult patients. Notably, the model exhibited a high negative predictive value and relatively low PPV because we chose a balanced cutoff between sensitivity and specificity to ensure as high a TP as possible, which inevitably leads to a high FP and low false negative. Especially for external validation-2 (Yuedong Hospital), which had a very low incidence rate of postoperative SIRS (20/307, 6.5%), 16 TP were successfully predicted with a high sensitivity of 0.800, which comes with 89 FP and results in a low PPV (0.152) and F1 score (0.256).
The model indicators used in this study include preoperative fever, ASA, PT, hsCRP, BUN, diabetes, duration of surgery, ulinastatin, methylprednisolone, ALT, total volume of fluid loss, volume of blood loss, DBILI, albumin, and gender. These indicators are mainly related to the individual disease characteristics and are not affected by the level of different medical institutions or regional characteristics, which makes the model more generalizable. The results of our study further prove that the model has a good generalization ability for populations with different SIRS incidences. The high recall of our model is important for reminders to check patients early and prevent SIRS in advance; this demonstrates a more responsible attitude toward patients.
Currently, given the more severe mortality and adverse prognosis, most studies have adopted sepsis as a clinical endpoint [
]. In our study, we used SIRS as the primary outcome because it has been an acknowledged criterion that is easier to identify and can help physicians notice the possibility of sepsis and prescribe tests to examine whether infection truly exists.As the population ages, the surgical population is also aging faster than the general population, with higher morbidity and mortality rates [
]. Notably, older adults are predisposed to postoperative infections, SIRS, and even sepsis due to preexisting comorbidities, repeated and prolonged hospitalizations, immune dysregulation, and functional limitations [ ]. Although preoperative antimicrobial prophylaxis has been routinely administered for older adult patients in various specialized operations, the persistent high incidence of postoperative SIRS suggests that it cannot be effectively prevented in this way [ ]. In fact, for older patients undergoing different types of surgery, there is still a lack of effective tools to identify high-risk patients with postoperative SIRS and assist with decision-making on the need for individualized interventions.In this study, we used ML methods to analyze diverse data types [
] due to the advantages of flexibility and scalability. A predictive model based on an RF algorithm was developed to identify older adult patients with a high risk of postoperative SIRS. Internal validation and two external validations confirmed that the established model could predict postoperative SIRS with high accuracy and specificity. The results might be important derivatives and supplements to the current perioperative prevention and management programs, which enable surgeons and anesthesiologists to identify older adult patients who are suspected of having postoperative SIRS. In addition to screening high-risk groups, this model can also help prevent and treat postoperative SIRS in older adult patients more accurately and in a timelier manner by using various drug or nondrug means under the guideline of enhanced recovery after surgery, so as to promote the short-term and long-term prognoses of patients [ ]. Finally, an online risk calculator was developed to improve clinical usability and make our model accessible to anesthesiologists and peers around the world.Comparison With Prior Work
Distinguished from previous investigations that mainly focused on a single indicator or a single surgery, we fully used the perioperative data of patients and constructed an optimal combination of risk factors to predict postoperative SIRS in older adult patients. In this study, 15 variables were identified to be significantly associated with postoperative SIRS, including preoperative fever, ASA [
], PT, hsCRP, BUN, diabetes [ ], duration of surgery [ ], ulinastatin, methylprednisolone, ALT, total volume of fluid loss, volume of blood loss, DBILI [ ], albumin, and gender [ ]. These variables have also been reported to be associated with postoperative SIRS and sepsis in earlier studies, adding clinical credibility to our model. Meanwhile, all the variables were routinely recorded and widely used in clinical practice, which makes the model more feasible and can be widely used in different hospitals.Methylprednisolone and ulinastatin have also been associated with postoperative SIRS, which may be attributed to the fact that both medicines are widely used among high-risk surgical patients with postoperative infection according to anesthesiologists’ clinical experience [
- ]. Additionally, intraoperative fluid loss ranks first in the feature importance weight of the RF model, which indicates that fluid management such as intraoperative intravenous infusion should be given higher priority during the perioperative period to prevent postoperative SIRS, and this was consistent with the consensus on early management of sepsis [ ].Limitations
Notably, several limitations must be listed here, including that (1) this is a retrospective cohort study with collection and entry bias, as well as possible residual confounding, which requires future prospective studies to validate the model. In addition, some indicators for SOFA scoring were missing, so we could not perform a comparative study between our model and SOFA scoring. (2) We selected 36 variables based on the availability in the EHR, correlation with SIRS risk, and predictive potential, but it should be noted that we may have missed other indicators with more predictive performance in postoperative SIRS due to the limitation of our data. (3) The model demonstrated a low PPV because we wanted the model to have a relatively high recall rate to predict more patients who were truly at a high risk of postoperative SIRS, which would inevitably lead to more FPs, but from a health economics perspective, the economic burden associated with enhanced perioperative management of high-risk patients is much less than that resulting from the progression of the patient to SIRS or even after sepsis, resulting in medical-economic stress. (4) The generalizability of this model in different ethnic groups and different regions also needs further validation. (5) It should be emphasized that estimates in our model are predictive and should not be interpreted as causal [
], such as the association between intraoperative use of methylprednisolone and ulinastatin and the higher SIRS incidence rate. Intraoperative use of such drugs is likely a marker of risk stratification with a lower risk of infection patients using these drugs than those at high risk.Conclusions
We enrolled 3 independent cohorts to develop and validate a generalizable RF model for the prediction of postoperative SIRS in older adult patients that enables surgeons and anesthesiologists to screen susceptible and high-risk populations for SIRS in older adult surgical patients and to implement early individualized interventions based on existing prevention and management programs.
Acknowledgments
The authors thank all the patients who kindly participated in this study.
This study was supported partly by the Key-Area Research and Development Program of Guangdong Province (number 2020B0101130015); Special Support Project of Guangdong Province (0720240209); the Natural Science Foundation of Guangdong Province (grant number 2022A1515012603); Science and Technology Program of Guangzhou, China (grant number 2024A04J4246); and the “Five and five” Project of the Third Affiliated Hospital of Sun Yat-Sen University (grant number 2023WW501) and Science and Technology Planning Project of Guangdong Province-Regional Innovation Capacity and Support System Construction (grant number 2023B110006).
Data Availability
The raw data supporting the conclusions of this article will be made available by the corresponding authors via email.
Authors' Contributions
CC, ZL, and YZ conceived the study. CC, ZL, YZ, and HM designed the study. HM, YF, TL, XL, YZ, and SZ collected and analyzed the data. CC, HM, YF, XL, and YZ wrote the manuscript. All authors edited and approved the manuscript.
Conflicts of Interest
None declared.
Missing rates, formulas for evaluation indicators, deleted variables, internal validation results after applying SMOTE, external validation, and the online calculator.
DOCX File , 1358 KBReferences
- Jeong H, Cha BG, Kang D, Kim DY, Yang W, Ki S, et al. Ceria nanoparticles fabricated with 6-aminohexanoic acid that overcome systemic inflammatory response syndrome. Adv Healthc Mater. May 2019;8(9):e1801548. [CrossRef] [Medline]
- Simpson SQ. SIRS in the time of sepsis-3. Chest. Jan 2018;153(1):34-38. [CrossRef] [Medline]
- Serafim R, Gomes JA, Salluh J, Póvoa P. A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest. Mar 2018;153(3):646-655. [CrossRef] [Medline]
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. Feb 23, 2016;315(8):801-810. [FREE Full text] [CrossRef] [Medline]
- Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence. Jan 01, 2014;5(1):20-26. [FREE Full text] [CrossRef] [Medline]
- Bown MJ, Nicholson ML, Bell PRF, Sayers RD. The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair. J Vasc Surg. Mar 2003;37(3):600-606. [FREE Full text] [CrossRef] [Medline]
- Wu W, Zhang D, Jin T, Lu T, Zhou F. Progress in the study of biomarkers for early prediction of systemic inflammatory response syndrome after percutaneous nephrolithotomy. Front Immunol. 2023;14:1142346. [FREE Full text] [CrossRef] [Medline]
- Liu D, Huang S, Sun J, Zhang H, Cai Q, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. Oct 09, 2022;9(1):56. [FREE Full text] [CrossRef] [Medline]
- Ferraris VA, Ballert EQ, Mahan A. The relationship between intraoperative blood transfusion and postoperative systemic inflammatory response syndrome. Am J Surg. Apr 2013;205(4):457-465. [CrossRef] [Medline]
- Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Ann Surg. Dec 2010;252(6):1065-1071. [FREE Full text] [CrossRef] [Medline]
- Boonmee P, Ruangsomboon O, Limsuwat C, Chakorn T. Predictors of mortality in elderly and very elderly emergency patients with sepsis: a retrospective study. West J Emerg Med. Oct 06, 2020;21(6):210-218. [FREE Full text] [CrossRef] [Medline]
- Chen C, Chen X, Chen J, Xing J, Hei Z, Zhang Q, et al. Association between preoperative hs-CRP/albumin ratio and postoperative SIRS in elderly patients: a retrospective observational cohort study. J Nutr Health Aging. 2022;26(4):352-359. [FREE Full text] [CrossRef] [Medline]
- Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. May 2019;20(5):e262-e273. [CrossRef] [Medline]
- Zhu Y, Liu X, Li Y, Yi B. The applications and prospects of big data in perioperative anesthetic management. APS. Aug 26, 2024;2(3):1. [CrossRef]
- Li C, Zhou R, Chen G, Hao X, Zhu T. Knowledge mapping and research hotspots of artificial intelligence on ICU and Anesthesia: from a global bibliometric perspective. APS. Oct 23, 2023;1(4):1. [CrossRef]
- Yan MY, Gustad LT, Nytrø Ø. Sepsis prediction, early detection, and identification using clinical text for machine learning: a systematic review. J Am Med Inform Assoc. Jan 29, 2022;29(3):559-575. [FREE Full text] [CrossRef] [Medline]
- Zheng Y, Wang J, Ling Z, Zhang J, Zeng Y, Wang K, et al. A diagnostic model for sepsis-induced acute lung injury using a consensus machine learning approach and its therapeutic implications. J Transl Med. Sep 12, 2023;21(1):620. [FREE Full text] [CrossRef] [Medline]
- Fan Z, Jiang J, Xiao C, Chen Y, Xia Q, Wang J, et al. Construction and validation of prognostic models in critically Ill patients with sepsis-associated acute kidney injury: interpretable machine learning approach. J Transl Med. Jun 22, 2023;21(1):406. [FREE Full text] [CrossRef] [Medline]
- Faisal M, Scally A, Richardson D, Beatson K, Howes R, Speed K, et al. Development and external validation of an automated computer-aided risk score for predicting sepsis in emergency medical admissions using the patient's first electronically recorded vital signs and blood test results. Crit Care Med. Apr 2018;46(4):612-618. [CrossRef] [Medline]
- Hu C, Li L, Huang W, Wu T, Xu Q, Liu J, et al. Interpretable machine learning for early prediction of prognosis in sepsis: a discovery and validation study. Infect Dis Ther. Jun 10, 2022;11(3):1117-1132. [FREE Full text] [CrossRef] [Medline]
- Mao Q, Jay M, Hoffman JL, Calvert J, Barton C, Shimabukuro D, et al. Multicentre validation of a sepsis prediction algorithm using only vital sign data in the emergency department, general ward and ICU. BMJ Open. Jan 26, 2018;8(1):e017833. [FREE Full text] [CrossRef] [Medline]
- Nemati S, Holder A, Razmi F, Stanley MD, Clifford GD, Buchman TG. An interpretable machine learning model for accurate prediction of sepsis in the ICU. Crit Care Med. Apr 2018;46(4):547-553. [FREE Full text] [CrossRef] [Medline]
- Fleuren LM, Klausch TLT, Zwager CL, Schoonmade LJ, Guo T, Roggeveen LF, et al. Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med. Mar 2020;46(3):383-400. [FREE Full text] [CrossRef] [Medline]
- Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. Apr 2003;31(4):1250-1256. [CrossRef] [Medline]
- Ward A, Sarraju A, Chung S, Li J, Harrington R, Heidenreich P, et al. Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population. NPJ Digit Med. Sep 23, 2020;3(1):125. [FREE Full text] [CrossRef] [Medline]
- Riley RD, Ensor J, Snell KIE, Harrell FE, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. Mar 18, 2020;368:m441. [CrossRef] [Medline]
- Luo W, Phung D, Tran T, Gupta S, Rana S, Karmakar C, et al. Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view. J Med Internet Res. Dec 16, 2016;18(12):e323. [FREE Full text] [CrossRef] [Medline]
- Li X, Lu Y, Chen C, Luo T, Chen J, Zhang Q, et al. Development and validation of a patient-specific model to predict postoperative SIRS in older patients: A two-center study. Front Public Health. 2023;11:1145013. [FREE Full text] [CrossRef] [Medline]
- Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. Journal of Artificial Intelligence Research. Jun 01, 2002;16:321-357. [FREE Full text] [CrossRef]
- Torgo L. An infra-structure for performance estimation and experimental comparison of predictive models in R. arXiv. 2015:1. [FREE Full text] [CrossRef]
- Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in Python. Journal of Machine Learning Research. 2011;12:2825-2830. [FREE Full text]
- Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. Sep 2020;585(7825):357-362. [FREE Full text] [CrossRef] [Medline]
- Chen T, Guestrin C. XGBoost: a scalable tree boosting system. KDD '16: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2016:785-794. [CrossRef]
- McKinney W. pandas: a Foundational Python Library for Data Analysis and Statistics. 2011. URL: https://docslib.org/doc/4231522/a-foundational-python-library-for-data-analysis-and-statistics [accessed 2024-11-12]
- R Core Team. R: A language and environment for statistical computing. Vienna, Austria. R Foundation for Statistical Computing; 2021. URL: https://www.R-project.org/ [accessed 2024-11-12]
- Caculation tool of Random Forest model to estimate SIRS. The Third Affiliated Hospital, Sun-Yat-Sen University. URL: https://analysis.aidcloud.cn/cn/sirs/ [accessed 2024-11-11]
- Fowler AJ, Abbott TEF, Prowle J, Pearse RM. Age of patients undergoing surgery. Br J Surg. Jul 2019;106(8):1012-1018. [CrossRef] [Medline]
- Nasa P, Juneja D, Singh O. Severe sepsis and septic shock in the elderly: An overview. World J Crit Care Med. Feb 04, 2012;1(1):23-30. [FREE Full text] [CrossRef] [Medline]
- Chen C, Li X, Luo G, Zhou S, Hei Z. Realising the full potential of anaesthesiology to promote enhanced recovery after surgery programmes in China. Br J Anaesth. May 2021;126(5):e157-e159. [FREE Full text] [CrossRef] [Medline]
- Sood A, Abdollah F, Sammon JD, Arora N, Weeks M, Peabody JO, et al. Postoperative sepsis prediction in patients undergoing major cancer surgery. J Surg Res. Mar 2017;209:60-69. [CrossRef] [Medline]
- Blair LJ, Huntington CR, Cox TC, Prasad T, Lincourt AE, Gersin KS, et al. Risk factors for postoperative sepsis in laparoscopic gastric bypass. Surg Endosc. Apr 2016;30(4):1287-1293. [CrossRef] [Medline]
- Kreydin EI, Eisner BH. Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol. Oct 2013;10(10):598-605. [CrossRef] [Medline]
- Zhang H, Meng F, Lu S. Nomograms predicting the occurrence of sepsis in patients following major hepatobiliary and pancreatic surgery. Gastroenterol Res Pract. 2020;2020:9761878. [FREE Full text] [CrossRef] [Medline]
- Zuckerman SL, Lakomkin N, Stannard BP, Hadjipanayis CG, Shaffrey CI, Smith JS, et al. Incidence and predictive factors of sepsis following adult spinal deformity surgery. Neurosurgery. Nov 01, 2018;83(5):965-972. [CrossRef] [Medline]
- Takaki M, Ichikado K, Kawamura K, Gushima Y, Suga M. The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study. Crit Care. Jun 08, 2017;21(1):135. [FREE Full text] [CrossRef] [Medline]
- Shao Y, Zhang L, Deng L, Yao H. [Clinical study on effects of ulinastatin on patients with systemic inflammatory response syndrome]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. Apr 2005;17(4):228-230. [Medline]
- Shu H, Liu K, He Q, Zhong F, Yang L, Li Q, et al. Ulinastatin, a protease inhibitor, may inhibit allogeneic blood transfusion-associated pro-inflammatory cytokines and systemic inflammatory response syndrome and improve postoperative recovery. Blood Transfus. Jan 2014;12 Suppl 1(Suppl 1):s109-s118. [FREE Full text] [CrossRef] [Medline]
- Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. Nov 2021;47(11):1181-1247. [FREE Full text] [CrossRef] [Medline]
- Adibi A, Sin DD, Safari A, Johnson KM, Aaron SD, FitzGerald JM, et al. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study. Lancet Respir Med. Oct 2020;8(10):1013-1021. [CrossRef] [Medline]
Abbreviations
ALT: alanine aminotransferase |
ASA: American Society of Anesthesiologists |
AUC: area under the receiver operating curve |
BUN: blood urea nitrogen |
DBILI: direct bilirubin |
EHR: electronic health record |
EPV: events per variable |
FP: false positive |
hs-CRP: high-sensitivity C-reactive protein |
LASSO: least absolute shrinkage and selection operator |
LR: logistic regression |
ML: machine learning |
MLP: multilayer perceptron |
PACS: picture archiving and communication system |
PPV: positive predictive value |
PT: prothrombin time |
RF: random forest |
SIRS: systemic inflammatory response syndrome |
SMOTE: synthetic minority oversampling technique |
SOFA: Sequential Organ Failure Assessment |
TP: true positive |
Edited by A Coristine; submitted 19.02.24; peer-reviewed by B Yi, X Xu; comments to author 07.05.24; revised version received 20.05.24; accepted 04.11.24; published 22.11.24.
Copyright©Haiyan Mai, Yaxin Lu, Yu Fu, Tongsen Luo, Xiaoyue Li, Yihan Zhang, Zifeng Liu, Yuenong Zhang, Shaoli Zhou, Chaojin Chen. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 22.11.2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.